BFRI · Biofrontera Inc.
$1.42
+0.07 (+5.19%)
At close · Aug 18
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$19.31M
Shares
14.85M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-13 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-14 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-19 | Earnings conference call (announced in 8-K) | Earnings call |
| 2023-05-22 | Special Meeting of Stockholders | Shareholder meeting |
| 2023-03-08 | Fourth Quarter and Full Year 2022 Financial Results Conference Call | Earnings call |
| 2023-02-21 | MicroCap Rodeo Best Ideas Virtual Conference | Conference |
| 2023-01-09 | LHA Offsite during J.P. Morgan | Event |
| 2022-12-12 | Annual Meeting | Shareholder meeting |
| 2022-12-01 | Benchmark’s 11th Annual Discovery One-on-One Investor Conference | Conference |
| 2022-11-30 | A.G.P.’s Biotech Conference | Conference |
| 2022-11-14 | Third Quarter 2022 Financial Results and Business Update Conference Call | Earnings call |
| 2022-10-26 | LD Micro Main Event XV | Event |
| 2022-08-12 | Second Quarter 2022 Financial Results and Business Update Conference Call | Earnings call |
| 2022-05-13 | First Quarter 2022 Financial Results and Business Update Conference Call | Earnings call |
| 2022-04-08 | Q4 and FY 2021 Earnings Call | Earnings call |
| 2022-01-18 | Jan 18th, 2022 | Event |
| 2021-11-30 | Third Quarter Earnings Call | Earnings call |
| 2021-07-13 | July 13, 2021 9:00 AM EDT | Event |
Key facts
CIK
1858685
CUSIP
09077D209
13F (30d)
24 filings
23 filers
Visit website
Investor relations